Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Epstein-Barr Virus Infections × Watchful Waiting × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colonic Neoplasms 3 Urinary Bladder Neoplasms 1 Nasopharyngeal Carcinoma 1 Epstein-Barr Virus Infections 1 Colorectal Neoplasms 1

Interventions

dehydroftorafur 1 Watchful Waiting 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Platinum 1 Paclitaxel 1 Gemcitabine 1 Fluorouracil 1 Cisplatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02135042 2026-03-18

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NRG Oncology

Phase 2/3 Active not recruiting

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡